efficacy of semaglutide and tirzepatide in reducing liver fat vs vs retatrutide: the complete three-way comparison Tirzepatide vs. Semaglutide for Patients

Before beginning treatment, ask how your progress will be evaluated

Gan & Lee Pharmaceuticals reported on June 30, 2026 in Annals of Internal Medicine that its investigational GLP-1 receptor agonist bofanglutide, dosed once every two weeks, lowered HbA1c at least as much as weekly semaglutide in a 272-patient phase 2b trial in adults with type 2 diabetes

Real weight-loss medication pens should have unique identification codes and proper labeling

Improving metabolic health via lifestyle behavior changes that are linked to the reduction in chronic systemic inflammation is key

Important: IGF-1 is age-dependent

Thiazolidinediones in the treatment of insulin resistance and type II diabetes